More On

Texas’ deal in Risperdal case finalized

Johnson & Johnson will pay $158 million to end suit

A judge in Texas has finalized the $158 million settlement Johnson & Johnson (J&J) reached with the state in January over the marketing of its antipsychotic drug Risperdal.

Earlier this week, Thomson Reuters reported that the case was heading back to court, but plaintiffs were unsure of the reason. "As far as we knew, we had a solid settlement," Tom Kelley, a spokesman for Texas Attorney General Greg Abbott, told Thomson Reuters on Monday. "We'll have more information on Tuesday about what has caused [J&J] some concerns."


Cathleen Flahardy

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.